Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 4/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22021551 | 0.84 | TDP1 (0.36) | — | |
| SCHEMBL21054984 | 0.81 | SHBG (0.44) | LMNATSHRALDH1A1CNR2CNR1 | |
| SCHEMBL6537146 | 0.79 | CNR2 (0.49) | CNR2CNR1 | |
| SCHEMBL1930607 | 0.74 | NR1I2 (0.50) | LMNACA1CA2CA7CA14 | |
| SCHEMBL4733508 | 0.73 | LMNA (0.45) | LMNATSHRALDH1A1NT5ECNR2 | |
| SCHEMBL1930733 | 0.72 | NR1I2 (0.38) | LMNACA1CA2CA7CA14 | |
| SCHEMBL9812254 | 0.72 | S1PR2 (0.45) | LMNACA1CA2ALDH1A1SMN1; SMN2 | |
| SCHEMBL23059445 | 0.72 | LMNA (0.41) | LMNACA1CA2TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL28138846 | 0.72 | LMNA (0.43) | LMNATSHRALDH1A1NT5ECNR2 | |
| SCHEMBL1930900 | 0.71 | S1PR2 (0.44) | LMNACA1CA2ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220010234-A1 | ALKYLBENZENE SULFONATE DETERGENTS | THE LUBRIZOL CORPORATION (US) | 2022-01-13 | — | — | US | disclosed |
| WO-2020102672-A1 | ALKYLBENZENE SULFONATE DETERGENTS | THE LUBRIZOL CORPORATION (US) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220010234-A1 | ALKYLBENZENE SULFONATE DETERGENTS | DSG1, TRIB1, DSP | LMNA 3358/4885CA1 1532/4885CA2 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.